NYSE:BAX Baxter International (BAX) Stock Price, News & Analysis $35.51 +0.42 (+1.20%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$35.10▼$35.8650-Day Range$32.85▼$35.7152-Week Range$31.01▼$47.73Volume3.47 million shsAverage Volume4.15 million shsMarket Capitalization$18.10 billionP/E Ratio6.83Dividend Yield3.27%Price Target$42.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Baxter International alerts: Email Address Baxter International MarketRank™ Stock AnalysisAnalyst RatingHold2.17 Rating ScoreUpside/Downside20.2% Upside$42.67 Price TargetShort InterestHealthy1.74% of Shares Sold ShortDividend StrengthModerateBased on Four FactorsSustainability-1.95Upright™ Environmental ScoreNews Sentiment0.56Based on 9 Articles This WeekInsider TradingN/AProj. Earnings Growth9.28%From $2.91 to $3.18 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.76 out of 5 starsMedical Sector50th out of 936 stocksSurgical & Medical Instruments Industry10th out of 101 stocks 3.1 Analyst's Opinion Consensus RatingBaxter International has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 3 buy ratings, 8 hold ratings, and 1 sell rating.Amount of Analyst CoverageBaxter International has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Baxter International's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.74% of the outstanding shares of Baxter International have been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently increased by 3.39%, indicating that investor sentiment is decreasing. Previous Next 2.5 Dividend Strength Dividend YieldBaxter International pays a meaningful dividend of 3.27%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthBaxter International does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Baxter International is 22.31%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Baxter International will have a dividend payout ratio of 36.48% next year. This indicates that Baxter International will be able to sustain or increase its dividend.Read more about Baxter International's dividend. Previous Next 4.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreBaxter International has received a 55.71% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Vaccines (J07)", "Blood plasma proteins", and "Anaesthetics (N01)" products. See details.Environmental SustainabilityThe Environmental Impact score for Baxter International is -1.95. Previous Next 2.5 News and Social Media Coverage News SentimentBaxter International has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Baxter International this week, compared to 7 articles on an average week.Search InterestOnly 22 people have searched for BAX on MarketBeat in the last 30 days. This is a decrease of -21% compared to the previous 30 days.MarketBeat Follows10 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Baxter International insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.21% of the stock of Baxter International is held by insiders.Percentage Held by Institutions90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Baxter International's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Baxter International are expected to grow by 9.28% in the coming year, from $2.91 to $3.18 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Baxter International is 6.83, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.35.Price to Earnings Ratio vs. SectorThe P/E ratio of Baxter International is 6.83, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 156.32.Price to Earnings Growth RatioBaxter International has a PEG Ratio of 1.85. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBaxter International has a P/B Ratio of 2.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Baxter International's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIHeard about the 72-Hour Profit Surge? Read this…One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…Click here now to get all the details. About Baxter International Stock (NYSE:BAX)Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.Read More BAX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BAX Stock News HeadlinesJuly 25 at 6:36 AM | americanbankingnews.comStockNews.com Downgrades Baxter International (NYSE:BAX) to HoldJuly 25 at 3:23 AM | americanbankingnews.comBaxter International Inc. (NYSE:BAX) Receives $42.67 Average Price Target from BrokeragesJuly 26, 2024 | MarketBeat (Ad)We just added a $300 account credit to your MarketBeat subscriptionMarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $300 off your 2024-2025 subscription. Free for 30 days.July 23 at 4:21 AM | marketwatch.comBaxter International Inc. stock rises Monday, still underperforms marketJuly 22, 2024 | nz.finance.yahoo.comBaxter International Inc. (BTL.F)July 20, 2024 | marketwatch.comBaxter International Inc. stock underperforms Wednesday when compared to competitors despite daily gainsJuly 20, 2024 | marketwatch.comBaxter International Inc. stock remains steady Thursday, still outperforms marketJuly 18, 2024 | americanbankingnews.comBaxter International Inc. (NYSE:BAX) Announces Quarterly Dividend of $0.29July 26, 2024 | Colonial Metals (Ad)Collapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.July 17, 2024 | americanbankingnews.comBaxter International Sees Unusually Large Options Volume (NYSE:BAX)July 17, 2024 | rttnews.comBaxter Recalls Volara System Single-Patient Use Circuit July 16, 2024 | seekingalpha.comBaxter: Why Investors Should Take Advantage Of The Low ValuationJuly 9, 2024 | investorplace.com3 Bargain Bin Stocks with Millionaire-Maker PotentialJuly 8, 2024 | benzinga.comBaxter Recovers After Life2000 Ventilation Systems RecallJuly 8, 2024 | stocknews.com3 Growth Stocks With P/E Ratios Below Industry AverageJune 27, 2024 | insidermonkey.comDid Baxter International Inc. (BAX) Beat the Market in Q1?June 6, 2024 | businesswire.comBaxter to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceJune 5, 2024 | investorplace.com7 Deeply Undervalued Stocks to Buy Now or Regret LaterSee More Headlines Receive BAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Ex-Dividend for 7/1 Dividend5/31/2024Dividend Payable7/01/2024Today7/26/2024Next Earnings (Confirmed)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:BAX CUSIP07181310 CIK10456 Webwww.baxter.com Phone(224) 948-2000Fax224-948-1813Employees60,000Year Founded1931Price Target and Rating Average Stock Price Target$42.67 High Stock Price Target$54.00 Low Stock Price Target$30.00 Potential Upside/Downside+19.7%Consensus RatingHold Rating Score (0-4)2.17 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)$5.20 Trailing P/E Ratio6.85 Forward P/E Ratio12.24 P/E Growth1.85Net Income$2.66 billion Net Margins17.79% Pretax Margin-0.01% Return on Equity18.47% Return on Assets4.91% Debt Debt-to-Equity Ratio1.35 Current Ratio1.48 Quick Ratio1.01 Sales & Book Value Annual Sales$14.81 billion Price / Sales1.23 Cash Flow$5.26 per share Price / Cash Flow6.77 Book Value$16.69 per share Price / Book2.13Miscellaneous Outstanding Shares509,580,000Free Float508,510,000Market Cap$18.16 billion OptionableOptionable Beta0.57 Social Links The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Jose E. Almeida (Age 62)Chairman of the Board, President & CEO Comp: $3.62MMr. Joel T. Grade (Age 53)Executive VP & CFO Comp: $829.82kMs. Heather Knight (Age 52)Executive VP & Group President of Medical Products and Therapies Comp: $1.63MMr. Alok Sonig B.E. (Age 52)Mba, Executive VP & Group President of Pharmaceuticals Comp: $1.56MMr. Christopher A. Toth (Age 44)Executive VP & Group President of Kidney Care Comp: $5.26MMs. Tobi Karchmer M.D.M.S., Senior VP and Chief Medical & Scientific OfficerMs. Clare TrachtmanVice President of Investor RelationsMr. David S. Rosenbloom (Age 64)Executive VP & General Counsel Comp: $776.51kMs. Stacey Eisen?Senior Vice President, Chief Communications Officer & Corporate Marketing?Ms. Jeanne K. Mason Ph.D. (Age 68)?Executive VP & Chief Human Resources Officer Comp: $1.99MMore ExecutivesKey CompetitorsBecton, Dickinson and CompanyNYSE:BDXEdwards LifesciencesNYSE:EWDexComNASDAQ:DXCMIDEXX LaboratoriesNASDAQ:IDXXResMedNYSE:RMDView All CompetitorsInstitutional OwnershipBank of New York Mellon CorpBought 2,862,626 shares on 7/26/2024Ownership: 1.329%Raymond James Trust N.A.Sold 537 shares on 7/25/2024Ownership: 0.005%Field & Main BankSold 300 shares on 7/25/2024Ownership: 0.000%New York State Teachers Retirement SystemSold 41,270 shares on 7/24/2024Ownership: 0.083%First National Bank & Trust Co. of NewtownSold 3,090 shares on 7/23/2024Ownership: 0.004%View All Institutional Transactions Should I Buy Baxter International Stock? BAX Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in Baxter International Inc.: Baxter International Inc. has shown consistent growth in revenue and earnings, indicating a strong financial performance. Recent institutional investor activity, with notable increases in stake by major players, suggests confidence in the company's future prospects. The current stock price of Baxter International Inc. is trading at a relatively low level, potentially presenting a buying opportunity for investors. Baxter International Inc. has a diversified product portfolio in the medical instruments sector, reducing dependency on any single product or market. The company's historical track record of innovation and product development positions it well for future growth and competitiveness in the healthcare industry. Cons Investors should be bearish about investing in Baxter International Inc. for these reasons: Despite recent positive developments, Baxter International Inc. faces potential market volatility and regulatory challenges in the healthcare sector. The company's debt-to-equity ratio of 1.35 may raise concerns about its financial leverage and ability to manage debt obligations. Analyst reports indicating a consensus rating of "Hold" may suggest limited upside potential in the short term for Baxter International Inc. stock. Market competition and evolving industry trends could impact Baxter International Inc.'s market share and profitability in the future. Fluctuations in global economic conditions and healthcare policies may affect Baxter International Inc.'s revenue and earnings growth trajectory. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, July 5, 2024. Please send any questions or comments about these Baxter International pros and cons to contact@marketbeat.com. BAX Stock Analysis - Frequently Asked Questions How have BAX shares performed this year? Baxter International's stock was trading at $38.66 at the start of the year. Since then, BAX shares have decreased by 8.1% and is now trading at $35.51. View the best growth stocks for 2024 here. How were Baxter International's earnings last quarter? Baxter International Inc. (NYSE:BAX) posted its quarterly earnings results on Thursday, May, 2nd. The medical instruments supplier reported $0.65 EPS for the quarter, beating the consensus estimate of $0.61 by $0.04. The company's revenue for the quarter was down 1.6% compared to the same quarter last year. Read the conference call transcript. What is José (Joe) Almeida's approval rating as Baxter International's CEO? 506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees. Does Baxter International have any subsidiaries? The following companies are subsidiaries of Baxter International: Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and more. Who are Baxter International's major shareholders? Baxter International's top institutional shareholders include Bank of New York Mellon Corp (1.33%), Sumitomo Mitsui Trust Holdings Inc. (0.22%), New York State Teachers Retirement System (0.08%) and SG Americas Securities LLC (0.03%). Insiders that own company stock include Jeanne K Mason, Albert P L Stroucken, Jacqueline Kunzler and Brian Stevens. View institutional ownership trends. How do I buy shares of Baxter International? Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Baxter International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Xtrackers California Municipal Bond ETF (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC) and Abbott Laboratories (ABT). This page (NYSE:BAX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
